Blood Test for Tinnitus? Study Finds Elevated Prestin Protein in People With Ringing Ears

Researchers found elevated levels of the inner ear protein prestin in people with chronic tinnitus, a step toward an objective blood test for the condition.

Tinnitus, the perception of ringing, buzzing, or hissing sounds with no external source, affects millions of people worldwide. Yet for all its prevalence, doctors still have no objective test for it. Diagnosis rests entirely on what patients report, which makes the condition difficult to measure, track, and study.

A new study from the University of Connecticut takes a different approach. Instead of asking people to describe their tinnitus, the researchers drew blood and measured proteins that come from the inner ear itself. One of those proteins stood out.

Background: Why the Researchers Looked at This

The cochlea, the spiral shaped hearing organ of the inner ear, contains two kinds of sensory cells: inner hair cells, which send sound information to the brain, and outer hair cells, which amplify quiet sounds and sharpen hearing. Outer hair cells owe their amplifying ability to a motor protein called prestin, which lets them change shape thousands of times per second.

Earlier work has suggested that when outer hair cells are stressed or damaged, prestin can leak into the bloodstream. Because damage to outer hair cells has long been suspected of playing a role in tinnitus, the Connecticut team reasoned that people with tinnitus might carry measurably different prestin levels in their blood.

The researchers also measured three other inner ear proteins: otoferlin, which helps inner hair cells release chemical signals; connexin 26, which supports the cochlea's internal chemistry; and stereocilin, which is part of the hair bundle structure on outer hair cells. Together these four proteins offered a broad snapshot of cochlear health from a simple blood draw.

How the Study Was Done

The team recruited 82 adults at a tertiary academic medical center: 41 with chronic tinnitus in both ears and 41 comparison participants without tinnitus. Everyone underwent hearing tests, completed the Tinnitus Handicap Inventory, a standard questionnaire measuring how much tinnitus disrupts daily life, and gave a blood sample.

Notably, each participant also wore a personal noise dosimeter for a full week, which recorded their real world sound exposure. That mattered because loud noise by itself can shift prestin levels, so the researchers needed to separate the effect of tinnitus from the effect of a noisy job or lifestyle.

Protein concentrations were measured with enzyme linked immunosorbent assays, a standard laboratory technique. The statistical analysis then adjusted for age, hearing thresholds, and daily noise exposure, three factors that could otherwise blur the comparison.

What the Researchers Found

Serum prestin was significantly higher in the tinnitus group than in the comparison group, with a p value of .006. Importantly, the difference held up after the researchers controlled for age, hearing loss, and measured noise exposure, with the adjusted comparison reaching a p value of .003. In other words, the elevated prestin was not simply a byproduct of older ears or louder lives.

The other three proteins told a different story. Otoferlin, connexin 26, and stereocilin levels did not differ meaningfully between people with and without tinnitus. Connexin 26 and stereocilin did track with age and hearing thresholds, suggesting they may reflect general cochlear aging rather than tinnitus specifically.

One additional pattern caught the researchers' attention: prestin and stereocilin levels rose and fell together across participants, with a correlation of .51, and that relationship was stronger in the tinnitus group. Since both proteins come from outer hair cells, the finding reinforces the idea that these amplifier cells are involved in the condition.

Interestingly, none of the protein levels correlated with Tinnitus Handicap Inventory scores. A person's blood markers indicated whether tinnitus was present, but not how burdensome it felt, a reminder that the distress tinnitus causes involves more than the cochlea alone.

What It Means for People with Hearing Loss

For people who live with tinnitus, this line of research points toward something the field has never had: an objective, biological measure of the condition. A validated blood marker could one day help doctors confirm a diagnosis, track whether the underlying cochlear stress is improving, and test whether new therapies actually work.

The findings also strengthen the link between tinnitus and the health of the ear's outer hair cells, the same cells that are commonly affected in age related and noise related hearing loss. That helps explain why tinnitus and hearing loss so often travel together, and why addressing hearing itself is frequently part of managing the condition.

When Tinnitus and Hearing Loss Travel Together, Clearer Sound Can Help

This study adds biological evidence that tinnitus often involves the same outer hair cells that support everyday hearing, which is one reason many people with ringing ears also struggle to follow conversation. Hearing aids are not a treatment or cure for tinnitus, but for people who also have mild to moderate hearing loss, clearer everyday sound may make the ringing feel less noticeable by giving the brain more of the real world sound it has been missing.

Newer FDA-OTC hearing aids have made that kind of support easier to try at home. The Panda Quantum is one example: a 16-channel receiver in canal device with adaptive noise reduction built for clear speech in noisy environments, plus Bluetooth for calls, TV, and music. A single charge lasts 20 hours, and the charging case carries three additional full charges for 80 hours of total use.

Quantum also offers an optional app with an in-ear hearing test that can personalize gain and frequency response to your hearing profile, though the device works fully out of the box without the app or the test. It comes with a 5-year warranty and a 45-day trial that starts when you receive it. One caveat worth knowing: OTC hearing aids are approved for adults with mild to moderate hearing loss, and severe or profound loss still benefits most from a clinical fitting. Learn more at pandahearing.com.

Limitations of This Research

This was an observational study of 82 people at a single academic center, so it shows an association rather than proving that outer hair cell stress causes tinnitus. All participants had chronic, bilateral, non pulsatile tinnitus, which means the results may not extend to other tinnitus types. Blood levels of cochlear proteins can also be influenced by factors the study could not fully capture, and the assays used are research tools rather than approved clinical tests.

The absence of any correlation with tinnitus handicap scores also means a prestin test, if one is eventually validated, would indicate the presence of cochlear involvement rather than measure how much tinnitus affects a person's life. Larger, multi site studies will be needed before any blood test reaches the clinic.

Where This Leaves Us

Tinnitus has always been invisible to everyone except the person experiencing it. This study suggests that may not always be the case: a protein released by the ear's own amplifier cells was reliably elevated in people with chronic ringing, even after accounting for age, hearing, and noise exposure. If future work confirms prestin as a biomarker, it would give researchers a long missing objective anchor for diagnosing tinnitus and testing treatments, and it gives people with tinnitus fresh evidence that their condition has a measurable biological footprint.

Adamczyk P, Corsetti R, Preniqi Z, Kadian S, Sobel NE, Wolfson S, Roberts D, Skoe E, Parham K. Serum Levels of Prestin, Otoferlin, Connexin 26, and Stereocilin: A Biomarker Approach to Tinnitus. Otolaryngology-Head and Neck Surgery. 2026. Retrieved from PubMed. https://doi.org/10.1002/ohn.70382